• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腔内卡介苗治疗浅表性膀胱癌。

Intracavitary Bacillus Calmette-Guerin in the Treatment of Superficial Bladder Tumors.

机构信息

Departments of Urology, and Microbiology and Immunology, Queen's University, Kingston, Ontario, Canada.

出版信息

J Urol. 2017 Feb;197(2S):S142-S145. doi: 10.1016/j.juro.2016.10.101. Epub 2016 Dec 22.

DOI:10.1016/j.juro.2016.10.101
PMID:28012770
Abstract

Patients with recurrent superficial bladder tumors have been treated by vesical and intradermal administration of Bacillus Calmette-Guerin. The pattern of recurrence in 9 patients has been altered favorably. Although the findings are still preliminary they appear to hold promise of a new therapeutic approach to the treatment of a group of neoplasms for which effective therapy is still lacking.

摘要

复发性浅表膀胱癌患者已接受膀胱内和皮内卡介苗治疗。9 例患者的复发模式得到了有利改变。尽管这些发现仍处于初步阶段,但它们似乎为一组仍缺乏有效治疗方法的肿瘤提供了一种新的治疗方法。

相似文献

1
Intracavitary Bacillus Calmette-Guerin in the Treatment of Superficial Bladder Tumors.腔内卡介苗治疗浅表性膀胱癌。
J Urol. 2017 Feb;197(2S):S142-S145. doi: 10.1016/j.juro.2016.10.101. Epub 2016 Dec 22.
2
Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors.腔内卡介苗治疗浅表性膀胱肿瘤
J Urol. 1976 Aug;116(2):180-3. doi: 10.1016/s0022-5347(17)58737-6.
3
The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot study.自然杀伤细胞受体配体的表达水平可预测卡介苗治疗反应:一项初步研究。
J Urol. 2007 Dec;178(6):2660-4. doi: 10.1016/j.juro.2007.07.118. Epub 2007 Oct 22.
4
Prospective randomized comparison of intravesical with percutaneous bacillus Calmette-Guerin versus intravesical bacillus Calmette-Guerin in superficial bladder cancer.浅表性膀胱癌中膀胱内灌注卡介苗与经皮注射卡介苗对比膀胱内灌注卡介苗的前瞻性随机对照研究
J Urol. 1991 Apr;145(4):738-40. doi: 10.1016/s0022-5347(17)38439-2.
5
Maintenance intravesical bacillus calmette-guerin for superficial transitional cell carcinoma of bladder. A retrospective study.膀胱内维持使用卡介苗治疗浅表性膀胱移行细胞癌:一项回顾性研究。
Urology. 1990 Sep;36(3):222-5. doi: 10.1016/0090-4295(90)80259-p.
6
The response of patients with superficial bladder cancer to a second course of intravesical bacillus Calmette-Guerin.浅表性膀胱癌患者对第二疗程膀胱内卡介苗治疗的反应
J Urol. 1990 Apr;143(4):710-2; discussion 712-3. doi: 10.1016/s0022-5347(17)40067-x.
7
Superficial transitional cell carcinoma of the bladder associated with mucosal involvement of the prostatic urethra: results of treatment with intravesical bacillus Calmette-Guerin.膀胱浅表性移行细胞癌伴前列腺尿道黏膜受累:卡介苗膀胱灌注治疗的结果
J Urol. 1988 Feb;139(2):290-3. doi: 10.1016/s0022-5347(17)42389-5.
8
Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.经尿道切除浅表性膀胱癌后卡介苗的免疫预防性膀胱内应用。
Croat Med J. 2003 Apr;44(2):187-92.
9
A randomized prospective comparison of oral versus intravesical and percutaneous bacillus Calmette-Guerin for superficial bladder cancer.口服、膀胱内灌注及经皮注射卡介苗治疗浅表性膀胱癌的随机前瞻性比较
J Urol. 1990 Jul;144(1):65-7. doi: 10.1016/s0022-5347(17)39367-9.
10
[Intravesical bacillus Calmette-Guerin (BCG) in the treatment of superficial bladder tumors: effect of intravesical BCG on papillary tumors].膀胱内卡介苗(BCG)治疗浅表性膀胱肿瘤:膀胱内BCG对乳头状肿瘤的影响
Nihon Hinyokika Gakkai Zasshi. 1986 Oct;77(10):1623-30. doi: 10.5980/jpnjurol1928.77.10_1623.

引用本文的文献

1
The ladder of regulatory stringency and balance: an application to the US FDA's regulation of bacterial live therapeutics.监管严格性与平衡性的阶梯:应用于美国食品药品监督管理局对细菌活菌疗法的监管
Gut Microbes. 2025 Dec;17(1):2517377. doi: 10.1080/19490976.2025.2517377. Epub 2025 Jun 12.
2
Editorial: Vital role of innate immunity in cancer immunotherapy.社论:天然免疫在癌症免疫治疗中的重要作用。
Front Immunol. 2025 May 21;16:1594009. doi: 10.3389/fimmu.2025.1594009. eCollection 2025.
3
Infections Following Intravesical Bacillus Calmette-Guérin Instillation for Bladder Cancer in Western Australia: A 22-Year Retrospective Review.
西澳大利亚州膀胱癌患者膀胱内灌注卡介苗后的感染情况:一项为期22年的回顾性研究
Open Forum Infect Dis. 2025 Feb 7;12(2):ofaf070. doi: 10.1093/ofid/ofaf070. eCollection 2025 Feb.
4
From plague to the promise: The journey of Bacille Calmette-Guérin.从鼠疫到希望:卡介苗的历程。
Bladder (San Franc). 2024 Dec 30;11(4):e21200022. doi: 10.14440/bladder.2024.0035. eCollection 2024.
5
Role of Trained Immunity in Heath and Disease.训练有素的免疫在健康与疾病中的作用。
Curr Cardiol Rep. 2025 Jan 13;27(1):18. doi: 10.1007/s11886-024-02167-7.
6
A Novel Approach for Bladder Cancer Treatment: Nanoparticles as a Drug Delivery System.一种膀胱癌治疗的新方法:纳米颗粒作为药物递送系统。
Int J Nanomedicine. 2024 Dec 17;19:13461-13483. doi: 10.2147/IJN.S498729. eCollection 2024.
7
Prognostic value of neutrophil-to-lymphocyte ratio in patients with non-muscle-invasive bladder cancer with intravesical Bacillus Calmette-Guérin immunotherapy: a systematic review and meta-analysis.中性粒细胞与淋巴细胞比值对卡介苗膀胱内免疫治疗非肌层浸润性膀胱癌患者预后的价值:系统评价和荟萃分析。
Front Immunol. 2024 Oct 23;15:1464635. doi: 10.3389/fimmu.2024.1464635. eCollection 2024.
8
The Impact of Dose Reduction of Bacillus Calmette-Guerin on Oncological Outcomes and Toxicity in Non-Muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.卡介苗剂量减少对非肌层浸润性膀胱癌肿瘤学结局和毒性的影响:一项系统评价和荟萃分析
Bladder Cancer. 2023 Sep 25;9(3):227-236. doi: 10.3233/BLC-230044. eCollection 2023.
9
Research progress on the microbiota in bladder cancer tumors.膀胱癌肿瘤中微生物群的研究进展
Front Cell Infect Microbiol. 2024 Apr 8;14:1374944. doi: 10.3389/fcimb.2024.1374944. eCollection 2024.
10
Bladder Cancer: Immunotherapy and Pelvic Lymph Node Dissection.膀胱癌:免疫疗法与盆腔淋巴结清扫术
Vaccines (Basel). 2024 Jan 31;12(2):150. doi: 10.3390/vaccines12020150.